The findings build on a separate pilot study published in In that study, researchers found that semaglutide reduced the pace of biological aging in 42% of participants, slowed aging-related mortality risk markers in 34% of participants, and increased telomere-length markers in nearly half of participants, alongside improvements in physical function
The industry stands at a critical juncture where technical innovation, regulatory compliance and strategic partnerships will determine market success
Archived from the original on 21 April 2014
However, not for people with certain thyroid conditions and kidney disease
Developed originally as a treatment for type II diabetes, Mounjaro / tirzepatide quickly gained recognition for its amazing benefits beyond blood sugar management
Image Credit: nerudol/iStockWednesday Breakfast: Smoothie with protein powder, kale, mango, apple, and chia seeds